Real moms, real GLP-1 talk
Mood Changes on a GLP-1: What I Would Ask, and What FDA Found
The current FDA review of psychiatric safety, what it does and does not tell me about feeling flat, and when I would seek help for a mood change.
On this page
“Flat” is worth explaining in ordinary words
If my mood changed after starting a GLP-1, I would describe the change plainly. Sadness, anxiety, irritability, loss of interest and feeling emotionally muted are not interchangeable. I would explain what the symptom interrupts: sleep, work, relationships, eating or the ability to look after myself.
I would not assume the timing proves that the medicine caused it. I would also not dismiss the timing. My clinician needs both the symptom and when it began, including any change in dose, other medicines or a stressful event.
The FDA review changed the warning
On January 13, 2026, FDA requested removal of the suicidal-behavior and ideation warning from affected GLP-1 weight-management medicines after its review found no increased risk. Its meta-analysis included 91 placebo-controlled trials and 107,910 participants; the analysis did not show increased risk of the psychiatric outcomes assessed1.
I would read that as reassuring population evidence, not a promise that an individual cannot experience depression or another mental-health problem. Removing a drug warning does not make new symptoms unimportant. I would still contact my clinician about a worrying change rather than wait for a label to tell me what I am feeling.
I would also separate the question of suicide risk from the question of feeling emotionally flat. A large safety review does not fully answer whether someone experiences a change in pleasure, motivation or the role food plays in daily life.
A small record can help me be specific
If symptoms are mild enough to record safely, I would note my sleep, meal pattern, medicine timing and how the day felt. I would include whether the change is constant or comes in episodes. A record should help the appointment, not become another burden or delay getting support.
I would write down concrete changes: avoiding friends, finding ordinary activities unrewarding, crying more often, or feeling unable to concentrate. “I am not myself” can be the opening sentence, but examples help another person understand what I mean.
If fatigue is the main problem, I would use the tiredness guide to prepare that part of the conversation. Exhaustion, disrupted sleep and reduced intake can overlap with mood symptoms without explaining them completely.
Eating changes deserve support too
If food used to organize breaks, celebrations or comfort, I would ask what has changed now that appetite is different. I would want help building satisfying routines without assuming I must be grateful for losing interest in every part of eating.
I would also look at whether I can eat adequately. My protein and nutrition questions cover a practical food-plan discussion. They do not establish that a nutrient deficiency is causing my mood, and I would not diagnose one from a difficult week.
If binge eating is part of my history, I would tell the clinician rather than treat reduced appetite as proof that the disorder has resolved. The binge-eating evidence guide distinguishes early research from established treatment. I would want appropriate mental-health care alongside any weight-management prescription.
The rest of my medicine list matters
I would bring all prescription and nonprescription medicines to a review, including recent starts or dose changes. I would not stop an antidepressant or adjust my GLP-1 because an online story sounds similar to mine.
If I take an oral medicine with a narrow safety margin, I would ask whether the oral-medication interaction questions apply to me. Changes in stomach emptying and changes in my medicine routine are reasons for a pharmacist's assessment, not proof that every oral medicine has stopped working2.
When I would ask for help promptly
I would contact a healthcare professional promptly for worsening depression, persistent loss of interest or anxiety that interferes with daily life. I would say if I am struggling to care for myself or feel unsafe. My plan would include who can respond when the usual office is closed.
If I have thoughts of harming myself, feel in immediate danger or cannot stay safe, I would seek emergency help immediately and ask a trusted person to stay with me. I would not wait for a routine refill appointment or try to resolve an immediate safety concern by changing medication on my own.
What I would want from the appointment
I would want an assessment that considers my whole health, clear next steps and a follow-up date. I would ask whether medication changes are appropriate and who will coordinate them. That leaves room for the symptom to be taken seriously without deciding the cause before anyone has assessed it.
If poor sleep is part of the story, the nighttime reflux questions might help me describe one possible interruption. My goal would be support for the actual problem I am having, with evidence and individual care both in the conversation.
Frequently asked questions
Did FDA find increased suicide risk with GLP-1 medicines?
FDA’s January 2026 review did not find an increased risk and requested removal of the affected warnings. That population finding does not make an individual mood change unimportant; new or worsening symptoms still deserve care.
Should I stop my medicine if I feel emotionally flat?
Discuss the symptom and all medicines with your clinician rather than changing treatment yourself. Seek emergency help immediately if you feel unsafe or have thoughts of harming yourself.
References
- U.S. Food and Drug Administration (2026). FDA Requests Removal of Suicidal Behavior and Ideation Warning from GLP-1 RA Medications. FDA. https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp
- Eli Lilly and Company (2026). Zepbound prescribing information: oral medications. Lilly. https://pi.lilly.com/us/zepbound-uspi.pdf
One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.
Continue reading
Tired on a GLP-1? The Questions I Would Bring to My Clinician
How I would investigate fatigue during GLP-1 treatment: the limits of trial numbers, food intake, dehydration, sleep, low glucose and medication review.
ReadHow Much Protein on a GLP-1? The Food Plan I Would Ask For
Protein targets during GLP-1 weight loss, why kidney history changes the calculation, and how I would combine food planning with strength and follow-up.
ReadQuieter Food Thoughts Are Not the Same as Treating Binge-Eating Disorder
What a small randomized trial found about binge episodes, why weight loss is a different outcome, and how to ask for eating-disorder care.
ReadThe Pharmacy Review I Would Request Before Starting a GLP-1
Delayed stomach emptying does not make every pill ineffective. What to bring to a pharmacist review and why tablet and injection instructions differ.
ReadHeartburn After Bedtime: Sorting Out Reflux on a GLP-1
Nighttime heartburn needs a practical meal and medication plan, plus attention to swallowing problems, bleeding and chest pain.
ReadWomen’s GLP-1 Effects: Hair, Mood and Lean Tissue
Hair thinning, mood, 'Ozempic face,' muscle loss — the women's-side effects nobody warns you about, each with real research and a when-to-call line.
Read